Hypothesis: Insulin Sensitization Assay

Query: You are a professional biomedical researcher, having experience in early-stage drug discovery and validation in vitro. Your task is to evaluate cell culture assays that would be used to evaluate drugs to treat Polycystic Ovary Syndrome.
        Given the following assay, do a comprehensive literature review to evaluate if this assay would be useful for testing therapeutics for Polycystic Ovary Syndrome. Search relevant literature across
        biomedical, clinical, and biochemical literature about the disease or therapeutic landscape. Don't look up specific drugs, but any relevant scientific information that may inform assay development.Strategy: Insulin Sensitization Assay
Reasoning: Quantify insulin-stimulated glucose uptake in human granulosa cells using fluorescent glucose analogs (e.g., 2-NBDG) to directly measure restoration of IR/PI3K/Akt signaling defects characteristic of PCOS (wang2023signalingpathwaysand; ryu2019animalmodelsfor). This simple, rapid readout correlates with insulin resistance phenotypes and is amenable to medium-throughput screening.Provide your response in the following format, like an evaluation for a scientific proposal:
        Assay Overview: Explain the assay idea, including the following key points: which aspect of the disease pathogenesis does the assay model, what measurements will be taken from the assay and how they will be taken, which cells or other biological material are used in the assay.
        Biomedical Evidence: Make a compelling argument for how the aspect of the disease represented in the assay is central to the pathogenesis of the disease. Make sure to consider both the biomedical and clinical literature.
        Previous Use: Explain how this assay has previously been used for drug discovery (if this has been done). Explain any key scientific discoveries which have been made using this assay.
        Overall Evaluation: Strengths and weaknesses of this assay for testing therapeutics for Polycystic Ovary Syndrome.

Assay Overview:
The proposed insulin sensitization assay is designed to quantify insulin-stimulated glucose uptake in human granulosa cells using fluorescent glucose analogs, such as 2-NBDG. The assay directly measures the restoration of defects in the insulin resistance (IR)/phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. In this model, human granulosa cells—key mediators in ovarian folliculogenesis—serve as the experimental system because they exhibit functional insulin signaling and are directly implicated in the pathogenesis of Polycystic Ovary Syndrome (PCOS). The measurement is achieved by monitoring the fluorescence intensity changes over time after insulin administration, which correlates with glucose uptake, thereby serving as a quantitative readout of the efficacy of therapeutic compounds in restoring insulin sensitivity (OpenTargets Search: Polycystic Ovary Syndrome-INSR,PIK3CA,AKT1).

Biomedical Evidence:
PCOS is endocrinologically characterized by insulin resistance not only at a systemic level but also in ovarian tissues. Granulosa cells in PCOS patients exhibit reduced insulin-stimulated glucose uptake and an attenuated activation of the PI3K/Akt pathway, as shown by decreased levels of phosphorylated Akt (p-Akt) and impaired GLUT4 translocation. This dysfunction is a central component of PCOS pathogenesis and correlates with reproductive abnormalities such as impaired follicular development and oocyte quality (anjali2015fshstimulatesirs2 pages 1-2). Clinical studies have further validated that defects in IRS-2/PI3K/Akt signaling are intricately linked to the ovarian metabolic aberrations observed in PCOS patients (chahal2021directimpactof pages 6-9). The assay’s focus on insulin-stimulated glucose uptake thus directly models a key aspect of PCOS pathogenesis by reflecting the cellular phenotype of insulin resistance and allows for an assessment of pharmacologic interventions aimed at correcting these molecular defects (belani2023investigatingthepotential pages 1-2, zhu2022elevatedsaa1promotes pages 1-2).

Previous Use:
Previous investigations have extensively utilized insulin sensitization assays in granulosa cells to delineate the molecular aberrancies associated with PCOS. Studies employing various experimental interventions such as metformin or novel bioactive molecules have demonstrated that improving PI3K/Akt pathway activity in granulosa cells correlates with enhanced glucose uptake and restored metabolic function (wang2021humaninalleviatesinsulin pages 11-12, chahal2021directimpactof pages 15-17). Moreover, these assays have provided mechanistic insights by linking gonadotropin-induced signaling defects—involving IRS-2 expression and GLUT4 translocation—to impaired glucose uptake in PCOS granulosa cells (anjali2015fshstimulatesirs2 pages 11-13). Although the explicit use of this assay for high-throughput drug screening in PCOS has not been widely reported in clinical trial settings (Clinical Trials Search: granulosa cells AND insulin resistance AND Polycystic Ovary Syndrome AND in vitro), the cumulative evidence supports its translational potential in early-stage drug discovery and validation of insulin sensitizing agents (belani2018differentialinsulinand pages 25-26).

Overall Evaluation:
The strengths of this assay lie in its direct mechanistic relevance and applicability. By quantifying insulin-stimulated glucose uptake in human granulosa cells, the assay captures a fundamental defect observed in PCOS at the cellular level. It allows for rapid and quantitative assessment of insulin signaling via the IR/PI3K/Akt pathway, making it amenable to medium-throughput screening. This simplicity, combined with its strong face and construct validity supported by clinical and biochemical studies, positions the assay as a valuable platform for testing novel insulin-sensitizing therapeutics (chahal2021directimpactof pages 36-44, kong2017insulinresistanceenhances pages 11-12).

However, some limitations include the inherent variability of primary human granulosa cell cultures and the challenge of fully recapitulating the in vivo ovarian microenvironment in vitro. Additionally, while restoration of insulin-stimulated glucose uptake is indicative of improved metabolic function, it may not capture the complete spectrum of PCOS-related endocrine and paracrine dysfunctions. Nonetheless, as a screening tool in early-stage drug discovery, the assay is scientifically robust and justified by extensive biomedical evidence (wang2021humaninalleviatesinsulin pages 12-13).

References:
1. (OpenTargets Search: Polycystic Ovary Syndrome-INSR,PIK3CA,AKT1): Open Targets Query (Polycystic Ovary Syndrome-INSR,PIK3CA,AKT1, 20 results). Ochoa, D. et al. (2023). The next-generation Open Targets Platform: reimagined, redesigned, rebuilt. Nucleic Acids Research.

2. (anjali2015fshstimulatesirs2 pages 1-2): G. Anjali, Surleen Kaur, Ruchi Lakra, Jyoti Taneja, Gaganjot S. Kalsey, Anjali Nagendra, T.G. Shrivastav, M. Gouri Devi, Neena Malhotra, Alka Kriplani, and Rita Singh. Fsh stimulates irs-2 expression in human granulosa cells through camp/sp1, an inoperative fsh action in pcos patients. Cellular Signalling, 27:2452-2466, Dec 2015. URL: https://doi.org/10.1016/j.cellsig.2015.09.011, doi:10.1016/j.cellsig.2015.09.011. This article has 46 citations and is from a peer-reviewed journal.

3. (anjali2015fshstimulatesirs2 pages 11-13): G. Anjali, Surleen Kaur, Ruchi Lakra, Jyoti Taneja, Gaganjot S. Kalsey, Anjali Nagendra, T.G. Shrivastav, M. Gouri Devi, Neena Malhotra, Alka Kriplani, and Rita Singh. Fsh stimulates irs-2 expression in human granulosa cells through camp/sp1, an inoperative fsh action in pcos patients. Cellular Signalling, 27:2452-2466, Dec 2015. URL: https://doi.org/10.1016/j.cellsig.2015.09.011, doi:10.1016/j.cellsig.2015.09.011. This article has 46 citations and is from a peer-reviewed journal.

4. (belani2023investigatingthepotential pages 1-2): Muskaan A. Belani, Preeti Shah, Manish Banker, and Sarita S. Gupta. Investigating the potential role of swertiamarin on insulin resistant and non-insulin resistant granulosa cells of poly cystic ovarian syndrome patients. Journal of Ovarian Research, Mar 2023. URL: https://doi.org/10.1186/s13048-023-01126-0, doi:10.1186/s13048-023-01126-0. This article has 3 citations and is from a peer-reviewed journal.

5. (chahal2021directimpactof pages 15-17): Nidhi Chahal, Anjali Geethadevi, Surleen Kaur, Ruchi Lakra, Anjali Nagendra, T.G. Shrivastav, Francesco De Pascali, Eric Reiter, Pascale Crépieux, M. Gouri Devi, Neena Malhotra, K. Muralidhar, and Rita Singh. Direct impact of gonadotropins on glucose uptake and storage in preovulatory granulosa cells: implications in the pathogenesis of polycystic ovary syndrome. Metabolism, 115:154458, Feb 2021. URL: https://doi.org/10.1016/j.metabol.2020.154458, doi:10.1016/j.metabol.2020.154458. This article has 20 citations.

6. (chahal2021directimpactof pages 6-9): Nidhi Chahal, Anjali Geethadevi, Surleen Kaur, Ruchi Lakra, Anjali Nagendra, T.G. Shrivastav, Francesco De Pascali, Eric Reiter, Pascale Crépieux, M. Gouri Devi, Neena Malhotra, K. Muralidhar, and Rita Singh. Direct impact of gonadotropins on glucose uptake and storage in preovulatory granulosa cells: implications in the pathogenesis of polycystic ovary syndrome. Metabolism, 115:154458, Feb 2021. URL: https://doi.org/10.1016/j.metabol.2020.154458, doi:10.1016/j.metabol.2020.154458. This article has 20 citations.

7. (wang2021humaninalleviatesinsulin pages 11-12): Yingying Wang, Zhengyan Zeng, Shuhua Zhao, Li Tang, Jin Yan, Nianyu Li, Liping Zou, Xiaorong Fan, Chengcheng Xu, Jin Huang, Wei Xia, Changhong Zhu, and Meng Rao. Humanin alleviates insulin resistance in polycystic ovary syndrome: a human and rat model–based study. Endocrinology, Mar 2021. URL: https://doi.org/10.1210/endocr/bqab056, doi:10.1210/endocr/bqab056. This article has 17 citations and is from a domain leading peer-reviewed journal.

8. (wang2021humaninalleviatesinsulin pages 12-13): Yingying Wang, Zhengyan Zeng, Shuhua Zhao, Li Tang, Jin Yan, Nianyu Li, Liping Zou, Xiaorong Fan, Chengcheng Xu, Jin Huang, Wei Xia, Changhong Zhu, and Meng Rao. Humanin alleviates insulin resistance in polycystic ovary syndrome: a human and rat model–based study. Endocrinology, Mar 2021. URL: https://doi.org/10.1210/endocr/bqab056, doi:10.1210/endocr/bqab056. This article has 17 citations and is from a domain leading peer-reviewed journal.

9. (zhu2022elevatedsaa1promotes pages 1-2): Qinling Zhu, Yue Yao, Lizhen Xu, Hasiximuke Wu, Wangsheng Wang, Yaqiong He, Yuan Wang, Yao Lu, Jia Qi, Yingchang Ding, Xinyu Li, Jiaan Huang, Hanting Zhao, Yanzhi Du, K. Sun, and Yun Sun. Elevated saa1 promotes the development of insulin resistance in ovarian granulosa cells in polycystic ovary syndrome. Reproductive Biology and Endocrinology, Jan 2022. URL: https://doi.org/10.1186/s12958-021-00873-3, doi:10.1186/s12958-021-00873-3. This article has 15 citations and is from a peer-reviewed journal.

10. (belani2018differentialinsulinand pages 25-26): Muskaan Belani, Abhilash Deo, Preeti Shah, Manish Banker, Pawan Singal, and Sarita Gupta. Differential insulin and steroidogenic signaling in insulin resistant and non-insulin resistant human luteinized granulosa cells—a study in pcos patients. The Journal of Steroid Biochemistry and Molecular Biology, 178:283-292, Apr 2018. URL: https://doi.org/10.1016/j.jsbmb.2018.01.008, doi:10.1016/j.jsbmb.2018.01.008. This article has 65 citations.

11. (chahal2021directimpactof pages 36-44): Nidhi Chahal, Anjali Geethadevi, Surleen Kaur, Ruchi Lakra, Anjali Nagendra, T.G. Shrivastav, Francesco De Pascali, Eric Reiter, Pascale Crépieux, M. Gouri Devi, Neena Malhotra, K. Muralidhar, and Rita Singh. Direct impact of gonadotropins on glucose uptake and storage in preovulatory granulosa cells: implications in the pathogenesis of polycystic ovary syndrome. Metabolism, 115:154458, Feb 2021. URL: https://doi.org/10.1016/j.metabol.2020.154458, doi:10.1016/j.metabol.2020.154458. This article has 20 citations.

12. (kong2017insulinresistanceenhances pages 11-12): Linghui Kong, Qien Wang, Jiewen Jin, Zou Xiang, Taoyu Chen, Shanmei Shen, Hongwei Wang, Qian Gao, and Yong Wang. Insulin resistance enhances the mitogen-activated protein kinase signaling pathway in ovarian granulosa cells. PLOS ONE, 12:e0188029, Nov 2017. URL: https://doi.org/10.1371/journal.pone.0188029, doi:10.1371/journal.pone.0188029. This article has 20 citations and is from a peer-reviewed journal.
